IHI — iShares U.S. Medical Devices ETF
Data updated: 2026-06-15
IHI — iShares U.S. Medical Devices ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $3.17B AUM · 0.38% expense ratio · -11.0% 1-yr return. From SEC regulatory filings.
IHI Fund Overview
IHI — iShares U.S. Medical Devices ETF is a US ETF managed by iSHARES TRUST, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: iSHARES TRUST
- Category: United States Health Care Equity
- Assets under management: $3.17B
- 1-year return: -11.0%
- Ticker: IHI
- SEC CIK: 0001100663
- SEC series ID: S000009419
- Share class ID: C000025773
IHI Holdings
Top 10 holdings of iShares U.S. Medical Devices ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Abbott Laboratories | 16.98% |
| Intuitive Surgical, Inc. | 15.57% |
| Stryker Corporation | 10.76% |
| Medtronic Public Limited Company | 4.62% |
| Becton, Dickinson And Company | 4.57% |
| Edwards Lifesciences Corporation | 4.47% |
| Idexx Laboratories, Inc. | 4.44% |
| Resmed Inc. | 4.43% |
| Ge Healthcare Technologies Inc. | 4.40% |
| Boston Scientific Corporation | 4.28% |
IHI Portfolio Allocation
Asset-class allocation of iShares U.S. Medical Devices ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.8% |
| Cash & Equivalents | 1.2% |
IHI Performance
Total returns for IHI (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -14.1% |
| 1 year | -11.0% |
| 3 years (annualised) | 0.0% |
| 5 years (annualised) | -0.2% |
IHI Risk Information
Risk metrics for IHI, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.7%
IHI Costs and Fees
IHI costs about $38 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.38%
- Gross expense ratio: 0.38%
- Portfolio turnover: 16%
- Brokerage commissions: 0.16 bps of average net assets (SEC N-CEN)
IHI Cashflows
Over the 12 months to 2026-03, iShares U.S. Medical Devices ETF had net outflows of $1.06B, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$42.15M |
| 2026-02 | −$98.19M |
| 2026-01 | −$194.11M |
| 2025-12 | −$154.07M |
| 2025-11 | −$47.60M |
| 2025-10 | −$72.97M |
IHI Debt Constituents
No individual debt constituents are reported in iShares U.S. Medical Devices ETF's latest SEC N-PORT filing.
IHI Prospectus and SEC Filings
Official iShares U.S. Medical Devices ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.